CVE-2025-66485 IBM CVE debrief

Who should care

Defenders responsible for IBM Aspera Shares deployments should assess exposure and prioritize verification of affected versions. This includes operators, platform administrators, vulnerability management teams, and security teams. They should review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance, and plan vendor-supported updates or mitigations through normal change control where exposure is confirmed

Why it matters

The CVE-2025-66485 vulnerability in IBM Aspera Shares could allow attackers to conduct various attacks, including cross-site scripting, cache poisoning, or session hijacking. Defenders should prioritize verifying affected versions, assessing exposure, and updating HOST header validation to prevent injection attacks.

• Defenders must verify affected versions and assess exposure to prevent potential attacks.
• The vulnerability could lead to cross-site scripting, cache poisoning, or session hijacking if exploited.
• Defenders should prioritize updating HOST header validation to prevent injection attacks.

Technical summary

IBM Aspera Shares 1.9.9 through 1.11.0 is vulnerable to HTTP header injection due to improper validation of input by the HOST headers. This could allow an attacker to conduct various attacks, including cross-site scripting, cache poisoning, or session hijacking. The vulnerability affects IBM Aspera Shares deployments, and defenders should assess exposure and prioritize verification of affected versions. The CVE record and NVD entry provide details on the vulnerability, including its description, CVSS score, and affected versions.

Defensive priority

Defenders should prioritize verifying affected versions and assessing exposure, as the vulnerability could lead to various attacks.

Recommended defensive actions

• Verify if the system is using an affected version of IBM Aspera Shares (1.9.9 through 1.11.0) and assess exposure.
• Review and update HOST header validation to prevent injection attacks.
• Monitor for potential attacks, such as cross-site scripting, cache poisoning, or session hijacking.
• Consider implementing compensating controls, such as web application firewalls or intrusion detection systems.
• Review the supplied official advisory or CVE record to validate affected scope, severity, and vendor guidance.
• Plan vendor-supported updates or mitigations through normal change control where exposure is confirmed.
• Track exceptions, retest remediated assets, and close the item only after evidence is documented.

Evidence notes

The CVE record and NVD entry provide details on the vulnerability, including its description, CVSS score, and affected versions. The vulnerability affects IBM Aspera Shares 1.9.9 through 1.11.0, and defenders should verify affected versions and assess exposure. The source confidence is limited to the information provided in the CVE record and NVD entry.

Sources and references

Methodology and review provenance

AI-assisted synthesis based on stored public vulnerability evidence. System validation, approval state, and publication status do not by themselves establish human review of this revision. PatchSiren helps prioritize defensive review and does not prove exposure or remediation on any system.